摘要
目的：研究黄皮酰胺的主要代谢途径，为进一步研究黄皮酰胺代谢的立体选择性打下基础。方法：用大鼠肝微粒体体外温孵法对右旋黄皮酰胺（（＋）ｃｌａｕｓｅｎａｍｉｄｅ）进行温孵，用硅胶柱色谱、制备ＴＬＣ分离纯化代谢产物并通过光谱分析鉴定其结构。结果：分离得到５个代谢产物ＣＭ１，ＣＭ３，ＣＭ４，ＣＭ５及ＣＭ６，其结构分别鉴定为６羟基，４羟基，４，６二羟基，４苯环邻位羟基，４，７苯环间位二羟基黄皮酰胺。结论：黄皮酰胺的代谢主要发生羟化或双羟化，ＣＭ３是其主要代谢产物，量较少的ＣＭ４，ＣＭ６为其进一步代谢产生的双羟基代谢产物；另２个代谢产物ＣＭ１，ＣＭ５产生的量也较少；ＣＭ２未分离得到，但通过ＨＰＬＣ分析知其为右旋黄皮酰胺的微量代谢产物。
AIM: To find the metabolic pathway of (+)clausenamide in rat liver microsomal incubate and give the basis of studying the stereoselectivity of the metabolism of clansenamide. METHODS: (+)Clausenamide was incubated in rat liver microsomal incubate containing NADPHgenerating system and the metabolites were isolated and purified by using silica gel column and preparative TLC and then their structures were determined by 1HNMR and MS. RESULTS: Five metabolites, CM1, CM3, CM4, CM5 and CM6, were obtained, and their structures were determined as 6hydroxyl, 4hydroxyl, 4,6dihydroxyl, 4phenylorthohydroxyl, 4,7phenylmetodihydroxyl clausenamide by 1HNMR and FABMS. CONCLUSION: The metabolism of (+)clausenamide were hydroxylation or dihydroxylation. CM3 is the main monohydroxyl metabolite, both CM4 and CM6 are dihydroxoyl metabolites generated from CM3. The amount of the other two metabolites, CM1 and CM5, is much less. Although CM2 is not isolated from the incubate it is also detected by HPLC.
出处
《药学学报》
CAS
CSCD
北大核心
1999年第4期303-307,共5页
Acta Pharmaceutica Sinica
基金
国家自然科学基金
